Following a Moving Target: Current and Emerging Strategies for the Prevention and Management of COVID-19 in Patients with Multiple Sclerosis
Program DescriptionAs our understanding of COVID-19 ad
Category
Format
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Pathways to Progress: Outlining Key Steps to Diagnosis and Evolving Therapeutic Approaches in CIDP
Program DescriptionDespite recent advancements in chronic inflammatory demyelinating polyneuropathy (CIDP), significant challenges persist in its accurate diagnosis and optimal treatment. Throughout this program, Drs. Nicholas J. Silvestri, Christyn Edmundson, and Kelly G.
Category
Format
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Attendance
Pay It Forward: Bridging the Gaps Between Payers and Providers to Get the Medication Your Patient Needs When They Need It for Narcolepsy and Idiopathic Hypersomnia
Program DescriptionPatients with narcolepsy type 1 (NT-1), narcolepsy type 2 (NT-2), and idiopathic hypersomnia (IH) have a diverse range of clinical presentations and therapeutic needs that complicate the process of diagnosis and management.
Category
Format
Credits
  • 0.75 AMA PRA Category 1 Credit™
  • 0.75 Attendance
The Path to Least Resistance: The Emerging Role of Noncovalent BTK Inhibitors in CLL/SLL Across Clinical Practice Settings
Program DescriptionThe advent of covalent Bruton’s tyrosine kinase inhibitors (cBTKi) (e.g., ibrutinib) in chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL) has significantly enhanced long-term outcomes and quality-of-life for patients as the treatment landscape continu
Category
Format
Credits
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
Transforming the Course of Pompe: Advancements in the Care of Evolving Phenotypes for Patients With Late-Onset Disease
Program DescriptionNewborn screening (NBS) for Pompe disease (PD) enables earlier diagnosis and life-saving treatments, revealing a higher prevalence than previously known.
Category
Format
Credits
  • 1.00 AAPA Category I CME
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Attendance
Lost in Transition: Pearls From An Interactive Workshop to Improve the Journey to Adulthood in Spinal Muscular Atrophy
Program DescriptionHistorically, patients with the most severe forms of spinal muscular atrophy (SMA) were largely unable to survive into adulthood, and those that did often were treated with a palliative approach.
Category
Format
  • Conference / meeting
  • Webinar live
Credits
  • 0.50 AAPA Category I CME
  • 0.50 AMA PRA Category 1 Credit™
  • 0.50 Attendance
Overburdened, Undertreated: Developments in the Patient-Centered Management of Spasticity in Multiple Sclerosis
Program DescriptionOver 80% of patients with multiple sclerosis (MS) experience related spasticity.
Category
Format
Credits
The Hidden Side of Multiple Sclerosis: Harnessing Key Pathologies to Improve Outcomes Across the Multiple Sclerosis Spectrum
Program DescriptionThe understanding of MS pathophysiology h
Category
Format
Credits
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 ANCC
  • 1.00 Attendance
Navigating the Clinic: Applying Modern Evidence, Expert Insights, and Practice Simulations to Optimize Idiopathic Hypersomnia Management
Due to the unique educational design of this course, the content must be viewed and completed on the myCME platform.Program DescriptionIdio
Category
Format
Credits
Inside Myasthenia Gravis: Where Providers and Patients Diverge on Defining Treatment Success
Program DescriptionThe understanding and prognosis of patients with myasthenia gravis (MG) have made dramatic leaps since the advent of serological evaluation and immunotherapy.
Category
Format
Credits

Pages